CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Triple negative breast cancer- experience at tertiary care centre, South India

Author: 
Satyanarayan V. and Ashok Akula
Subject Area: 
Health Sciences
Abstract: 

Background: Triple negative breast carcinoma (TNBC), defined as tumors negative for ER, PR and Her 2 Neu receptors with distinct clinical entity characterised by aggressive behaviour, no specific targeted therapy and poor outcome. Aims and objectives: 1. To study clinicopathological variable in TNBC 2. To study outcome of different modalities of management in TNBC. Materials and Methods: A retrospective study was conducted based on hospital records in Department of General Surgery between March 2012 and October 2014. Inclusion criteria: All female patients with breast cancer who were treated in ESIC who had triple negative harmone receptors. Exclusion Criteria: No follow up records in cancer registry. Demography, Stage of disease at presentation, Management, response to neoadjuvant chemotherapy, Grade of tumour and follow up for 20 months were analyzed, All patients underwent either modified radical mastectomy, breast conservative surgery as standard of care depending of stage of disease and anthracycline based chemotherapy was used for neoadjuvant or adjuvant setting. Results: Out of 40 cases in the study period 30 cases (75%) belonged to age less than 45 years. Thirty two patients (82%) had premenopausal status. Predominant cases were in advanced stage. Out of 16 cases who received neo-adjuvant chemotheraphy 100% response was noted with complete response rate at 13%. Infiltration ductal carcinoma was most common histology noted and 60% had grade 3 tumor. At mean follow up of 20 months, recurrence rate was noted in 11% of cases. Conclusion: TNBC patients present at early age with high grade and advanced stage. Anthracycline based chemotherapy has excelled response when used in neoadjuvant settings.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran